Commercial vaccine provides cross-protection by reducing colonization of Salmonella enterica serovars Infantis and Hadar in turkeys
- 21 January 2024
- Vol. 42 (4) , 727-731
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- A Multidrug-Resistant Salmonella Infantis Clone is Spreading and Recombining in the United StatesMicrobial Drug Resistance, 2021
- Carriage and Gene Content Variability of the pESI-Like Plasmid Associated with Salmonella Infantis Recently Established in United States Poultry ProductionGenes, 2020
- Salmonella recovery from chicken bone marrow and cecal counts differ by pathogen challenge methodPoultry Science, 2019
- Cross-protective Salmonella vaccine reduces cecal and splenic colonization of multidrug-resistant Salmonella enterica serovar HeidelbergVaccine, 2019
- Salmonella enterica serovar Infantis from Food and Human Infections, Switzerland, 2010–2015: Poultry-Related Multidrug Resistant Clones and an Emerging ESBL Producing Clonal LineageFrontiers in Microbiology, 2017
- Salmonella Serogroup C: Current Status of Vaccines and Why They Are NeededClinical and Vaccine Immunology, 2016
- Prophylactic Administration of Vector-Encoded Porcine Granulocyte-Colony Stimulating Factor Reduces Salmonella Shedding, Tonsil Colonization, and Microbiota Alterations of the Gastrointestinal Tract in Salmonella-Challenged SwineFrontiers in Veterinary Science, 2016
- Emergence of a Clonal Lineage of Multidrug-Resistant ESBL-Producing Salmonella Infantis Transmitted from Broilers and Broiler Meat to Humans in Italy between 2011 and 2014PLOS ONE, 2015
- A unique megaplasmid contributes to stress tolerance and pathogenicity of an emergent S almonella enterica serovar Infantis strainEnvironmental Microbiology, 2014
- Salmonellavaccines in poultry: past, present and futureExpert Review of Vaccines, 2013